Single Use Bioreactors Market

Single Use Bioreactors Market Size, Growth by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecasts to 2026

Report Code: BT 2863 Aug, 2021, by marketsandmarkets.com

The global Single use Bioreactors Market boasts a total value of $3.4 billion in 2021 and is projected to register a growth rate of 21.1% to reach a value of $8.8 billion by 2026. Single Use Bioreactors (SUBs) are bioreactors that are used only once and are then disposed of after use. They are typically made of plastic and can come in a variety of sizes and shapes, depending on the application. SUBs are used in bioprocessing applications to create biopharmaceuticals, such as vaccines and therapeutic proteins. They are also used in cell and gene therapy, regenerative medicine and biofuel production. SUBs are designed for maximum convenience and flexibility in terms of setup, operation and cleaning. They can be quickly and easily set up and operated, and can reduce the risk of contamination due to their single-use nature.

Increase in patent expirations is expected to offer significant opportunities for the single use bioreactors market growth. As many patented products are going off-patent in the future, companies are falling short of funds to invest in their R&D pipelines., According to the Generics and Biosimilars Initiative Journal data, around twelve biological products with global sales of more than USD 67 billion was exposed to biosimilar competition in 2020. As a result, several biopharmaceutical manufacturers are incorporating single-use bioprocessing technologies into their development processes.

Single-use Bioreactors Market

To know about the assumptions considered for the study, Request for Free Sample Report

Single Use Bioreactors Market Growth Dynamics

Drivers: Reduced automation complexity

SUBs increase the quality of the end product by reducing automation complexity. In the case of stainless-steel bioreactors, the complexity of the bioreactor increases with the number of in and out points. In stainless steel bioreactors, many points need to be checked to maintain valve control or monitoring temperature. On the other hand, owing to the improved design, SUBs have fewer pipes, valves, and instruments, thus resulting in the need for less monitoring for valve control or temperature. Reduced design complexities in SUBs also eliminate the need for surface cleaning, eliminating contamination and cross-contamination of cultures. Contamination is a major problem while using traditional bioreactors. As a result, the overall manufacturing process with SUBs is simpler than traditional bioreactors.

Restraints: Regulatory concerns related to SUBs

In SUBs, end products are almost always made on a small scale. When these end products are scaled up to a larger scale, they must adhere to GMP standards of safety, efficiency, and effectiveness. A major concern regarding the use of SUBs during the scale-up or scale-down process is that the molecules do not give the same results as they do in clinical trials. Additionally, concerns raised due to the mixing principle of SUBs have also increased the stringency of regulations and restricted their use. For example, in wave-type SUBs, the mixing principle is unconventional and limited to a rocking movement, which leads to uneven mixing. This leads to errors in results obtained from manufacturing, which do not replicate clinical trial results. Hence, the safety and efficacy of the biologic being tested are not reliable, which could be a major concern in the application of SUBs.

Opportunities: Emerging markets

The growing presence of global and local pharmaceutical & biopharmaceutical companies in these countries is a major factor driving the demand of the market. For instance, In April 2020, India’s leading drug companies, including Lupin and Dr. Reddy’s, have had their pharmaceutical manufacturing facilities cleared with US Food and Drug Administration (USFDA) inspection. In 2020, Serum Institute and Bharat Biotech had expanded their COVID-19 vaccine manufacturing capacity and installed SU bioreactors. With the increase in pharmaceutical & biopharmaceutical manufacturing, government authorities in these countries focus on good manufacturing practices and validated laboratory procedures. Implementing regulatory measures to prohibit the import & supply of drugs (that are contaminated or impure after bioprocessing) is expected to increase the demand for cost-effective single-use systems in these countries.

Challenges: Need for improved single-use sensors

The availability of dependable, accurate, and low-cost sensors that meet the needs of SUBs is one of the key challenges in the market. The sensors used in SUBs need to be compatible with the existing SUB platforms and are required to manage the system without affecting the sterility of materials. Traditionally, sensors were installed in SUB systems, but this practice lowered the quality of the final product.

Ideally, sensors and SUBs should be delivered as a single unit where the sensor is pre-installed in the SUB, which ensures sterilization of both containers and sensors. However, till date, the quality of sensors available is not as per the GMP standards because of leachability and extractability issues. This creates challenges while using SUBs, though there is a scope for improvement in this segment of the market, such as the development of more accurate and individual process sensors for various parameters (pH, temperature, flow measurement, and quality of the product), which can then be embedded in the bioprocess workflow.

By product, the single-use bioreactor systems segment accounted for the largest share of the single use bioreactors market in 2020.

Based on product, the single-use bioreactors market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the single-use bioreactors market in 2020. SUB systems with a scale range of above 1500 liters has made significant contributions to the revenue generated by this segment in 2020. Above 1500L bioreactors enable a reduction in the capital, facility, and disposables cost by doubling the cell culture capacity in approximately the same floor space. It offers easy scale-up, rapid container loading, as well as easy transfer of cell culture.

Similarly, this segment is expected to grow at the highest CAGR via scale range during the forecast period. It is anticipated that commercial-scale GMP manufacturing will show significant growth in the coming years. This is probable as more molecules like monoclonal antibodies will shift from the development phase to the commercial-scale manufacturing phase. This shift will generally require manufacturing of 100 kilograms or more and will increasingly involve parallel tracks, continuous bioprocessing, and/or multiple facilities to adopt 1000L to 2000L SUS bioreactors.

By type, the stirred-tank SUBs segment accounted for the largest share of the single use bioreactors market in 2020.

Based on type, the single-use bioreactor market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the market in 2020. The large share of this segment can be attributed to factors such as the high preference for stirred-tank SUBs in the cultivation of aerobic microbial cultures. Stirred-tank SUBs promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

By type of cells, the mammalian cells segment accounted for the largest share of the single use bioreactors market in 2020.

Based on the type of cell, the global single-use bioreactors market is categorized into mammalian cells, bacterial cells, yeast cells, and other cells (insect and plant cells). In 2020, the mammalian cells segment accounted for the largest market share. Complex biomolecules such as functional monoclonal antibodies (mAbs) and other highly glycosylated proteins require a highly mechanized metabolic machinery, which is available only in mammalian cells. Mammalian cells are mostly used to produce therapeutic proteins and monoclonal antibodies and conduct cell-based assays. Mammalian expression systems also develop Virus-subunit proteins. SUBs have been successfully employed for mammalian cell cultures for the scales up to 2,000 liters volume used in clinical and commercial drug manufacturing facilities. There are relatively few engineering challenges, such as heat removal, O2 mass transfer, and process control in mammalian applications.

By molecule type, the monoclonal antibodies segment accounted for the largest share of the single use bioreactors market in 2020.

Based on molecule type, the global single-use bioreactors market is categorized into monoclonal antibodies (mAbs), vaccines, gene-modified cells, stem cells, and other molecules (recombinant proteins including growth factors & interferons, antisense, and RNA interference). In 2020, the monoclonal antibodies segment accounted for the largest share of the global single-use bioreactors market. Monoclonal antibodies (mAbs) are one of the largest segments of the biotech APIs market. For manufacturing mAbs, mammalian cells are increasingly being employed to impart dynamic therapeutic mechanisms of action successfully. The commercial success of mammalian cell-derived mAbs has led to increased demand for novel SUB systems that provide greater productivity & flexibility and reduce costs. SUBs have been successfully employed in manufacturing mAbs using mammalian cell cultures of up to 2,000-liter volume.

By application, the pharmaceutical manufacturing applications segment accounted for the largest share of the single use bioreactors market in 2020.

Based on application, the single-use bioreactors market is segmented into research & development, process development, and bioproduction. The bioproduction segment accounted for the largest share of the market in 2020. Bioproduction includes manufacturing therapeutic drugs based on biologics, such as protein-based therapeutics, vaccines, gene therapies, and cell therapies. Increasing competition for new indications and the launch of biosimilars in the market are the major factors that have put pressure on manufacturers to produce biopharmaceuticals at lower costs. With the use of single-use bioreactors, it is possible to implement an end-to-end manufacturing process. This technology has significantly reduced process liquid wastage, labour costs, and on-site quality and validation requirements.

By end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the single use bioreactors market in 2020.

Based on end users, the market is segmented into pharmaceutical and biopharmaceutical companies, CROs & CMOs, and academic and research institutes. The bioproduction segment accounted for the largest share of the market in 2020. The large share of pharmaceutical and biopharmaceutical companies in this market is attributed to increasing R&D in these companies and the increasing production of biologics.

North America accounted for the largest share of the single use bioreactors market in 2020.

In 2020, North America accounted for the largest share of the single-use bioreactors market, followed by Europe. The US dominates the North American single-use bioreactors market during the forecast period. The US is the largest market for biopharmaceuticals, accounting for around a third of the global market. It is the world leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), US pharmaceutical firms hold the intellectual property rights for most new medicines and conduct over half the world's R&D in pharmaceuticals.

Single-use Bioreactors Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Single Use Bioreactors Market Key Players

Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the single-use bioreactors market.

Scope of the Single Use Bioreactors Market Report

Report Metrics

Details

Market Size value 2026

USD 8.8 billion

Growth Rate

21.1% CAGR

Largest Market

North America

Market Dynamics

Drivers, Opportunities, Restraints & Challenges

Largest Share Segments

The single-use bioreactor systems, The stirred-tank SUBs, The mammalian cells, The monoclonal antibodies, The pharmaceutical manufacturing applications

Forecasts up to

2026

Market Segmentation

Product, Type, Type of Cell, Molecule Type, Application, End User and Region

Single Use Bioreactors Market Growth Drivers

  • Increasing adoption of SUBs among small companies and startups
  • Reduced automation complexity
  • Ease in the cultivation of marine organisms
  • Reduced energy and water consumption
  • Growing biologics market
  • Technological advancements in SUBs
  • Increasing biopharmaceutical R&D

Single Use Bioreactors Market Growth Opportunities

  • Patent expiry
  • Emerging markets

Geographies covered

North America, Europe, APAC, Latin America and Middle East & Africa

The study categorizes the single use bioreactors market into the following segments and subsegments:

By Product

  • Single-use Bioreactor Systems
    • Up to 10L
    • 11–100L
    • 101–500L
    • 501–1500L
    • Above 1500L
  • Single-use Media Bags
    • 2D Bags
    • 3D Bags
    • Other Bags
  • Single-use Filtration Assemblies
  • Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)

By Type

  • Stirred-tank SUBs
  • Wave-induced SUBs
  • Bubble-column SUBs
  • Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)

By Type of Cell

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Other Cells (Insect and plant cells)

By Molecule Type

  • Monoclonal Antibodies
  • Vaccines
  • Gene-modified cells
  • Stem Cells
  • Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)

By Application

  • Research and Development (R&D)
  • Process Development
  • Bioproduction

By End User

  • Pharmaceutical & Biopharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Latin America
  • The Middle East and Africa

Recent Developments

  • In 2020, Sartorius Stedim Biotech (France) launched BIOSTAT STR Generation 3 Single-Use Bioreactor
  • In 2019, Pall Corporation (US) entered into a partnership with Freeline (UK) to implement its iCELLis bioreactor system in the Freeline’s adeno-associated virus (AAV) manufacturing platform. This partnership aims to achieve commercial scale and quality production of AAV gene therapy vectors.
  • In 2018, Getinge (Sweden) acquired Applikon Biotechnology (Netherlands), a leading provider of bioreactor systems. This acquisition will strengthen Getinge’s Life Science business segment in the single-use bioreactors market.
  • In 2017, Merck Millipore (Germany) allied with Samsung BioLogics (South Korea) to provide biopharmaceutical manufacturing and single-use solutions.
  • In 2017, Merck Millipore (Germany) opened a Mobius single-use manufacturing facility in Wuxi, China, to support the biopharma industry development in China.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 54)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 60)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOREACTOR MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE-BASED ESTIMATION), 2020
           FIGURE 4 SINGLE-USE BIOREACTOR MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS) 2020
           FIGURE 5 SINGLE-USE BIOREACTOR MARKET SIZE ESTIMATION (DEMAND-SIDE ANALYSIS) FOR 2020
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
           FIGURE 7 SINGLE-USE BIOREACTOR MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
           FIGURE 8 SINGLE-USE BIOREACTOR MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
           2.3.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 9 MARKET FORECAST VALIDATION FROM PRIMARY SOURCES
           2.3.2 DATA TRIANGULATION
                    FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
           2.4.1 COVID-19 SPECIFIC ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 73)
    FIGURE 11 MARKET SHARE, BY PRODUCT, 2020
    FIGURE 12 MARKET SHARE, BY TYPE, 2020
    FIGURE 13 MARKET SHARE, BY TYPE OF CELL, 2020
    FIGURE 14 MARKET SHARE, BY TYPE OF MOLECULE, 2020
    FIGURE 15 MARKET SHARE, BY APPLICATION, 2020
    FIGURE 16 MARKET, BY END USER, 2020 (USD MILLION)
    FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE SINGLE-USE BIOREACTOR MARKET, 2020

4 PREMIUM INSIGHTS (Page No. - 78)
    4.1 MARKET OVERVIEW
           FIGURE 18 INCREASING ADOPTION OF SUBS AMONG SMALL COMPANIES AND STARTUPS TO SUPPORT THE MARKET GROWTH
    4.2 NORTH AMERICA: MARKET SHARE, BY PRODUCT & COUNTRY (2020)
           FIGURE 19 THE SINGLE-USE BIOREACTOR SYSTEMS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
    4.3 MARKET SHARE, BY END USER, 2021 VS. 2026
           FIGURE 20 THE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    4.4 MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
           FIGURE 21 THE BIOPRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 22 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD (2021-2026)

5 MARKET OVERVIEW (Page No. - 83)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 23 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           TABLE 1 MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of SUBs among small companies and startups
                               FIGURE 24 ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING (2019)
                    5.2.1.2 Reduced automation complexity
                    5.2.1.3 Ease in the cultivation of marine organisms
                    5.2.1.4 Reduced energy and water consumption
                    5.2.1.5 Growing biologics market
                               FIGURE 25 GLOBAL BIOLOGICS MARKET, 2014-2023 (USD BILLION)
                    5.2.1.6 Technological advancements in SUBs
                    5.2.1.7 Increasing biopharmaceutical R&D
                               FIGURE 26 GLOBAL R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010-2025 (USD BILLION)
           5.2.2 RESTRAINTS
                    5.2.2.1 Regulatory concerns related to SUBs
                    5.2.2.2 Issues related to leachables and extractables
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Patent expiry
                               TABLE 2 US: BIOLOGICS GOING OFF-PATENT DURING 2018–2025
                    5.2.3.2 Emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Need for improved single-use sensors
                    5.2.4.2 Standardization of single-use designs
    5.3 KEY INDUSTRY TRENDS
           5.3.1 INCREASING FOCUS OF SINGLE-USE BIOPROCESSING CAPACITIES AND TECHNOLOGICAL COMPETITIVENESS
                    TABLE 3 SINGLE-USE BIOREACTOR CAPACITY EXPANSIONS BY MAJOR PLAYERS
           5.3.2 INCREASING ADOPTION OF SINGLE-USE SYSTEMS BY CONTRACT MANUFACTURING ORGANIZATIONS
           5.3.3 ADVENT OF AUTOMATION IN SINGLE-USE BIOREACTORS
    5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE SINGLE-USE BIOREACTOR MARKET
           FIGURE 27 SINGLE-USE BIOREACTOR MARKET SCENARIO WITH AND WITHOUT THE COVID-19 IMPACT (2019-2021)
    5.5 TRENDS/DISRUPTIONS IMPACTING CONSUMER BUSINESS
           FIGURE 28 REVENUE SHIFT FOR SUB PROVIDERS
    5.6 PRICING ANALYSIS
           TABLE 4 AVERAGE SELLING PRICE OF LAB SCALE SINGLE-USE BIOREACTORS BY REGION (2019)
           TABLE 5 APAC: AVERAGE COST OF SINGLE-USE BAGS/CYCLE (2020)
    5.7 VALUE CHAIN ANALYSIS
           FIGURE 29 VALUE CHAIN ANALYSIS ECOSYSTEM OF SINGLE-USE BIOREACTORS: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
    5.8 TECHNOLOGICAL ANALYSIS
           5.8.1 WAVE-INDUCED MOTION TECHNOLOGY
           5.8.2 BUBBLE-COLUMN TECHNOLOGY
           5.8.3 STIRRED-TANK TECHNOLOGY
           5.8.4 VERTICALLY PERFORATED DISCS
    5.9 PORTER’S FIVE FORCES ANALYSIS
           TABLE 6 SINGLE-USE BIOREACTOR MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.9.1 THREAT FROM NEW ENTRANTS
           5.9.2 THREAT FROM SUBSTITUTES
           5.9.3 BARGAINING POWER OF SUPPLIERS
           5.9.4 BARGAINING POWER OF BUYERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 PATENT ANALYSIS
           FIGURE 30 NUMBER OF SINGLE-USE BIOREACTOR MARKET PATENTS GRANTED (2010–2020)
           5.10.1 LIST OF RECENT PATENTS
    5.11 REGULATORY LANDSCAPE
           5.11.1 NORTH AMERICA
                    5.11.1.1 US
                               TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
                               TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.11.1.2 Canada
                    5.11.1.3 Europe

6 SINGLE-USE BIOREACTOR MARKET, BY PRODUCT (Page No. - 105)
    6.1 INTRODUCTION
           TABLE 9 MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 10 MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
    6.2 SINGLE-USE BIOREACTOR SYSTEMS
           6.2.1 THE SINGLE-USE BIOREACTOR SYSTEMS SEGMENT DOMINATED THE MARKET IN 2020
                    TABLE 11 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 12 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 13 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 14 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 15 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 16 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 17 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 18 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 19 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION)
                    TABLE 20 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION)
                    TABLE 21 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (UNITS)
                    TABLE 22 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (UNITS)
           6.2.2 UP TO 10L
                    TABLE 23 UP TO 10L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 24 UP TO 10L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.3 11–100L
                    TABLE 25 11–100L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 26 11–100L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.4 101–500L
                    TABLE 27 101–500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 28 101–500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.5 501–1500L
                    TABLE 29 501–1500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 30 501–1500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.6 ABOVE 1500L
                    TABLE 31 ABOVE 1,500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 32 ABOVE 1,500L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
    6.3 SINGLE-USE MEDIA BAGS
           6.3.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESS OPERATIONS DRIVE MARKET GROWTH FOR THIS SEGMENT
                    TABLE 33 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 34 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 35 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 36 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 37 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY,  2017–2020 (USD MILLION)
                    TABLE 38 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 39 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 41 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                    TABLE 42 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION)
           6.3.2 2D BAGS
                    TABLE 43 2D BAGS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 44 2D BAGS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.3 3D BAGS
                    TABLE 45 3D BAGS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 46 3D BAGS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.4 OTHER BAGS
                    TABLE 47 OTHER BAGS MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 48 OTHER BAGS MARKET, BY REGION, 2021–2026 (USD MILLION)
    6.4 SINGLE-USE FILTRATION ASSEMBLIES
           6.4.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE FILTRATION ASSEMBLIES
                    TABLE 49 SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 50 SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 51 NORTH AMERICA: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 52 NORTH AMERICA: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 53 EUROPE: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 54 EUROPE: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 55 ASIA PACIFIC: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 56 ASIA PACIFIC: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    6.5 OTHER PRODUCTS
           TABLE 57 OTHER PRODUCTS MARKET, BY REGION, 2017–2020 (USD MILLION)
           TABLE 58 OTHER PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
           TABLE 59 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 60 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 61 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 62 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 63 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY/REGION, 2017–2020 (USD MILLION)
           TABLE 64 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2026 (USD MILLION)

7 SINGLE USE BIOREACTORS MARKET, BY TYPE (Page No. - 131)
    7.1 INTRODUCTION
           TABLE 65 MARKET, BY TYPE, 2017–2020 (USD MILLION)
           TABLE 66 MARKET, BY TYPE, 2021–2026 (USD MILLION)
    7.2 STIRRED-TANK SINGLE-USE BIOREACTORS
           7.2.1 STIRRED-TANK SUBS ARE MOSTLY PREFERRED IN THE CULTIVATION OF AEROBIC MICROBIAL CULTURES
                    TABLE 67 STIRRED-TANK MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 68 STIRRED-TANK MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 69 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 70 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 71 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 72 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 73 APAC: STIRRED-TANK SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 74 APAC: STIRRED-TANK SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    7.3 WAVE-INDUCED SINGLE-USE BIOREACTORS
           7.3.1 LOW INVESTMENT COSTS AND SUCCESSFUL APPLICATIONS HAVE INCREASED THE ADOPTION OF WAVE-INDUCED SUBS IN THE BIOREACTORS MARKET
                    TABLE 75 WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 76 WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 77 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET,  BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 78 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET,  BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 79 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 80 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 81 APAC: WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 82 APAC: WAVE-INDUCED SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    7.4 BUBBLE-COLUMN SINGLE-USE BIOREACTORS
           7.4.1 GREATER MASS AND HEAT TRANSFER EFFICIENCIES DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 83 BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 84 BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 85 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 86 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORSMARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 87 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 88 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 89 APAC: BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 90 APAC: BUBBLE-COLUMN SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
    7.5 OTHER SINGLE-USE BIOREACTORS
           TABLE 91 OTHER SINGLE-USE BIOREACTOR MARKET, BY REGION, 2017–2020 (USD MILLION)
           TABLE 92 OTHER SINGLE-USE BIOREACTOR MARKET, BY REGION, 2021–2026 (USD MILLION)
           TABLE 93 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 94 NORTH AMERICA: OTHER SUBs MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 95 EUROPE: OTHER SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 96 EUROPE: OTHER SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 97 APAC: OTHER SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 98 APAC: OTHER SINGLE-USE BIOREACTOR MARKET, BY COUNTRY, 2021–2026 (USD MILLION)

8 SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL (Page No. - 146)
    8.1 INTRODUCTION
           TABLE 99 SINGLE-USE BIOREACTOR MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
           TABLE 100 SINGLE-USE BIOREACTOR MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
    8.2 MAMMALIAN CELLS
           8.2.1 MAMMALIAN CELLS ARE MOST WIDELY USED IN BIOMANUFACTURING OWING TO THEIR HIGHLY MECHANIZED METABOLIC MACHINERY
                    TABLE 101 MARKET FOR MAMMALIAN CELLS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 102 MARKET FOR MAMMALIAN CELLS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 103 NORTH AMERICA: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 104 NORTH AMERICA: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 105 EUROPE: MARKET FOR MAMMALIAN CELLS,  BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 106 EUROPE: MARKET FOR MAMMALIAN CELLS,  BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 107 APAC: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 108 APAC: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
    8.3 BACTERIAL CELLS
           8.3.1 THE USE OF BACTERIAL CELLS IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION DRIVES THE MARKET GROWTH
                    TABLE 109 MARKET FOR BACTERIAL CELLS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 110 MARKET FOR BACTERIAL CELLS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 111 NORTH AMERICA: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 112 NORTH AMERICA: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 113 EUROPE: MARKET FOR BACTERIAL CELLS,  BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 114 EUROPE: MARKET FOR BACTERIAL CELLS,  BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 115 APAC: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 116 APAC: MARKET FOR BACTERIAL CELLS,  BY COUNTRY, 2021–2026 (USD MILLION)
    8.4 YEAST CELLS
           8.4.1 FASTER GROWTH RATE AND MINIMAL REQUIREMENT OF GROWTH MEDIA CONDITIONS DRIVES THE ADOPTION OF YEAST CELLS IN RECOMBINANT PROTEIN PRODUCTION
                    TABLE 117 MARKET FOR YEAST CELLS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 118 MARKET FOR YEAST CELLS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 119 NORTH AMERICA: MARKET FOR YEAST CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 120 NORTH AMERICA: MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 121 EUROPE: MARKET FOR YEAST CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 122 EUROPE: MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 123 APAC: MARKET FOR YEAST CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 124 APAC: MARKET FOR YEAST CELLS, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
    8.5 OTHER CELLS
           TABLE 125 MARKET FOR OTHER CELLS, BY REGION, 2017–2020 (USD MILLION)
           TABLE 126 MARKET FOR OTHER CELLS, BY REGION, 2021–2026 (USD MILLION)
           TABLE 127 NORTH AMERICA: SINGLE-USE BIOREACTOR MARKET FOR OTHER CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 128 NORTH AMERICA: SINGLE-USE BIOREACTOR MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 129 EUROPE: SINGLE-USE BIOREACTOR MARKET FOR OTHER CELLS,  BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 130 EUROPE: SINGLE-USE BIOREACTOR MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 131 APAC: SINGLE-USE BIOREACTOR MARKET FOR OTHER CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 132 APAC: SINGLE-USE BIOREACTOR MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2026 (USD MILLION)

9 SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE (Page No. - 161)
    9.1 INTRODUCTION
           TABLE 133 SINGLE-USE BIOREACTOR MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
           TABLE 134 SINGLE-USE BIOREACTOR MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
    9.2 MONOCLONAL ANTIBODIES
           9.2.1 GROWING THERAPEUTIC APPLICATIONS OF MABS TO DRIVE THE DEMAND FOR SUBS IN R&D MANUFACTURING APPLICATIONS
                    TABLE 135 SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 136 SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 137 NORTH AMERICA: SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 138 NORTH AMERICA: SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 139 EUROPE: SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 140 EUROPE: SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 141 APAC: SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 142 APAC: SUBs MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2026 (USD MILLION)
    9.3 VACCINES
           9.3.1 IMPLEMENTATION OF SUBS FOR VACCINE PRODUCTION MAXIMIZES FACILITY OUTPUT AND INCREASES REVENUE
                    TABLE 143 SUBs MARKET FOR VACCINES, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 144 SUBs MARKET FOR VACCINES, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 145 NORTH AMERICA: SUBs MARKET FOR VACCINES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 146 NORTH AMERICA: SUBs MARKET FOR VACCINES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 147 EUROPE: SUBs MARKET FOR VACCINES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 148 EUROPE: SUBs MARKET FOR VACCINES, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 149 APAC: SUBs MARKET FOR VACCINES, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 150 APAC: SUBs MARKET FOR VACCINES, BY COUNTRY, 2021–2026 (USD MILLION)
    9.4 STEM CELLS
           9.4.1 WIDE APPLICATIONS OF STEM CELL THERAPIES FOR DISEASE TREATMENT DRIVES THE MARKET GROWTH OF THIS SEGMENT
                    TABLE 151 SUBs MARKET FOR STEM CELLS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 152 SUBs MARKET FOR STEM CELLS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 153 NORTH AMERICA: SUBs MARKET FOR STEM CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 154 NORTH AMERICA: SUBs MARKET FOR STEM CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 155 EUROPE: SUBs MARKET FOR STEM CELLS,  BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 156 EUROPE: SUBs MARKET FOR STEM CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 157 APAC: SUBs MARKET FOR STEM CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 158 APAC: SUBs MARKET FOR STEM CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
    9.5 GENE–MODIFIED CELLS
           9.5.1 THE GROWING MARKET OF GENE AND CELL THERAPIES FOR NEUROLOGICAL DISEASES AND CANCER TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 159 SUBs MARKET FOR GENE-MODIFIED CELLS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 160 SUBs MARKET FOR GENE-MODIFIED CELLS, BY REGION, 2021–2026 (USD MILLION)
                    TABLE 161 NORTH AMERICA: SUBs MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 162 NORTH AMERICA: SUBs MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 163 EUROPE: SUBs MARKET GENE –MODIFIED CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 164 EUROPE: SUBs MARKET GENE –MODIFIED CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
                    TABLE 165 APAC: SUBs MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2017–2020 (USD MILLION)
                    TABLE 166 APAC: SUBs MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2026 (USD MILLION)
    9.6 OHER MOLECULES
           TABLE 167 SUBs MARKET FOR OTHER MOLECULES, BY REGION, 2017–2020 (USD MILLION)
           TABLE 168 SUBs MARKET FOR OTHER MOLECULES, BY REGION, 2021–2026 (USD MILLION)
           TABLE 169 NORTH AMERICA: SUBs MARKET FOR OTHER MOLECULES, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 170 NORTH AMERICA: SUBs MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 171 EUROPE: SUBs MARKET FOR OTHER MOLECULES, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 172 EUROPE: SUBs MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2026 (USD MILLION)
           TABLE 173 APAC: SUBs MARKET FOR OTHER MOLECULES, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 174 APAC: SUBs MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2026 (USD MILLION)

10 SINGLE USE BIOREACTORS MARKET, BY APPLICATION (Page No. - 179)
     10.1 INTRODUCTION
               TABLE 175 GLOBAL MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
               TABLE 176 GLOBAL MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
     10.2 BIOPRODUCTION
             10.2.1 INCREASING COMPETITION FOR NEW INDICATIONS AND THE LAUNCH OF BIOSIMILARS DRIVES THE DEMAND FOR COST-EFFECTIVE SUBS
                       TABLE 177 SUBs MARKET FOR BIOPRODUCTION, BY REGION, 2017–2020 (USD MILLION)
                       TABLE 178 SUBs MARKET FOR BIOPRODUCTION, BY REGION, 2021–2026 (USD MILLION)
                       TABLE 179 NORTH AMERICA: SUBs MARKET FOR BIOPRODUCTION, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 180 NORTH AMERICA: SUBs MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 181 EUROPE: SUBs MARKET FOR BIOPRODUCTION, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 182 EUROPE: SUBs MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 183 APAC: SUBs MARKET FOR BIOPRODUCTION, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 184 APAC: SUBs MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2026 (USD MILLION)
     10.3 PROCESS DEVELOPMENT
             10.3.1 REDUCED RISK OF CROSS-CONTAMINATION AND REDUCED OPERATIONAL COSTS MAKE SUBS THE MOST PREFERRED SOLUTION FOR PROCESS DEVELOPMENT
                       TABLE 185 SUBs MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2017–2020 (USD MILLION)
                       TABLE 186 SUBs MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)
                       TABLE 187 NORTH AMERICA: SUBs MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 188 NORTH AMERICA: SUBs MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 189 EUROPE: SUBs MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 190 EUROPE: SUBs MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 191 APAC: SUBs MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 192 APAC: SUBs MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
     10.4 RESEARCH AND DEVELOPMENT
             10.4.1 SUBS ARE INCREASINGLY ADOPTED FOR R&D APPLICATIONS AS IT IS AN ECONOMICAL AND FLEXIBLE OPTION
                       TABLE 193 SUBs MARKET FOR RESEARCH AND DEVELOPMENT,  BY REGION, 2017–2020 (USD MILLION)
                       TABLE 194 SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)
                       TABLE 195 NORTH AMERICA: SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 196 NORTH AMERICA: SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 197 EUROPE: SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 198 EUROPE: SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 199 APAC: SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 200 APAC: SUBs MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)

11 SINGLE USE BIOREACTORS MARKET, BY END USER (Page No. - 191)
     11.1 INTRODUCTION
               TABLE 201 SUBs MARKET, BY END USER, 2017–2020 (USD MILLION)
               TABLE 202 SUBs MARKET, BY END USER, 2021–2026 (USD MILLION)
     11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
             11.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOREACTORS
                       TABLE 203 SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION)
                       TABLE 204 SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION)
                       TABLE 205 NORTH AMERICA: SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 206 NORTH AMERICA: SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 207 EUROPE: SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 208 EUROPE: SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 209 APAC: SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 210 APAC: SUBs MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
     11.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) AND CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
             11.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF THIS END-USER SEGMENT
                       TABLE 211 SUBs MARKET FOR CROS & CMOS, BY REGION, 2017–2020 (USD MILLION)
                       TABLE 212 SUBs MARKET FOR CROS & CMOS, BY REGION,  2021–2026 (USD MILLION)
                       TABLE 213 NORTH AMERICA: SUBs MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 214 NORTH AMERICA: SUBs MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 215 EUROPE: SUBs MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 216 EUROPE: SUBs MARKET FOR CROS & CMOS,  BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 217 APAC: SUBs MARKET FOR CROS & CMOS,  BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 218 APAC: SUBs MARKET FOR CROS & CMOS,  BY COUNTRY/REGION, 2021–2026 (USD MILLION)
     11.4 ACADEMIC & RESEARCH INSTITUTES
             11.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE THE MARKET GROWTH
                       TABLE 219 SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION)
                       TABLE 220 SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION)
                       TABLE 221 NORTH AMERICA: SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 222 NORTH AMERICA: SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 223 EUROPE: SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 224 EUROPE: SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 225 APAC: SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 226 APAC: SUBs MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)

12 SINGLE USE BIOREACTORS MARKET, BY REGION (Page No. - 203)
     12.1 INTRODUCTION
               FIGURE 31 SUBs MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
               TABLE 227 SUBs MARKET, BY REGION, 2017–2020 (USD MILLION)
               TABLE 228 SUBs MARKET, BY REGION, 2021–2026 (USD MILLION)
     12.2 NORTH AMERICA
               FIGURE 32 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
               TABLE 229 NORTH AMERICA: MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
               TABLE 230 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
               TABLE 231 NORTH AMERICA: MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
               TABLE 232 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
               TABLE 233 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION)
               TABLE 234 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION)
               TABLE 235 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION)
               TABLE 236 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION)
               TABLE 237 NORTH AMERICA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
               TABLE 238 NORTH AMERICA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
               TABLE 239 NORTH AMERICA: MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
               TABLE 240 NORTH AMERICA: MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
               TABLE 241 NORTH AMERICA: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
               TABLE 242 NORTH AMERICA: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
               TABLE 243 NORTH AMERICA: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
               TABLE 244 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
               TABLE 245 NORTH AMERICA: MARKET, BY END USER, 2017–2020 (USD MILLION)
               TABLE 246 NORTH AMERICA: MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.2.1 US
                       12.2.1.1 The US dominates the North American single use bioreactors market during the forecast period
                                   TABLE 247 US: MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 248 US: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 249 US: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 250 US: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 251 US: MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 252 US: MARKET, BY TYPE OF MOLECULE,  2021–2026 (USD MILLION)
                                   TABLE 253 US: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 254 US: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 255 US: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 256 US: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 257 US: MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 258 US: MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.2.2 CANADA
                       12.2.2.1 A growing number of biopharmaceutical manufacturing facilities supports market growth in Canada
                                   FIGURE 33 CANADA BIOLOGICS SALES (2009-2018)
                                   TABLE 259 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 260 CANADA: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 261 CANADA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 262 CANADA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 263 CANADA: MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 264 CANADA: MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                                   TABLE 265 CANADA: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 266 CANADA: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 267 CANADA: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 268 CANADA: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 269 CANADA: MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 270 CANADA: MARKET, BY END USER, 2021–2026 (USD MILLION)
     12.3 EUROPE
               TABLE 271 EUROPE: SINGLE USE BIOREACTORS MARKET, BY COUNTRY,  2017–2020 (USD MILLION)
               TABLE 272 EUROPE: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
               TABLE 273 EUROPE: MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
               TABLE 274 EUROPE: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
               TABLE 275 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION)
               TABLE 276 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION)
               TABLE 277 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION)
               TABLE 278 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,  2021–2026 (USD MILLION)
               TABLE 279 EUROPE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
               TABLE 280 EUROPE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
               TABLE 281 EUROPE: MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
               TABLE 282 EUROPE: MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
               TABLE 283 EUROPE: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
               TABLE 284 EUROPE: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
               TABLE 285 EUROPE: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
               TABLE 286 EUROPE: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
               TABLE 287 EUROPE: MARKET, BY END USER, 2017–2020 (USD MILLION)
               TABLE 288 EUROPE: MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.3.1 GERMANY
                       12.3.1.1 Increasing adoption of single-use bioreactors by biopharma companies and CDM0s to drive the market growth in Germany
                                   TABLE 289 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 290 GERMANY: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 291 GERMANY: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 292 GERMANY: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                   TABLE 293 GERMANY: MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 294 GERMANY: MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                                   TABLE 295 GERMANY: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 296 GERMANY: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 297 GERMANY: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 298 GERMANY: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 299 GERMANY: MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 300 GERMANY: MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.3.2 UK
                       12.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies, including single-use bioreactors in the UK
                                   TABLE 301 UK: SINGLE USE BIOREACTORS MARKET, BY PRODUCT,  2017–2020 (USD MILLION)
                                   TABLE 302 UK: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 303 UK: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 304 UK: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 305 UK: MARKET, BY TYPE OF MOLECULE,  2017–2020 (USD MILLION)
                                   TABLE 306 UK: MARKET, BY TYPE OF MOLECULE,  2021–2026 (USD MILLION)
                                   TABLE 307 UK: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 308 UK: MARKET, BY TYPE OF CELL,  2021–2026 (USD MILLION)
                                   TABLE 309 UK: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 310 UK: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 311 UK: MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 312 UK: MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.3.3 FRANCE
                       12.3.3.1 Increasing investments in life sciences R&D infrastructure development to support the market growth in France
                                   TABLE 313 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 314 FRANCE: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 315 FRANCE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 316 FRANCE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 317 FRANCE: MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 318 FRANCE: MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                                   TABLE 319 FRANCE: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 320 FRANCE: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 321 FRANCE: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 322 FRANCE: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 323 FRANCE: MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 324 FRANCE: MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.3.4 REST OF EUROPE (ROE)
                       TABLE 325 ROE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                       TABLE 326 ROE: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                       TABLE 327 ROE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 328 ROE: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 329 ROE: MARKET, BY TYPE OF MOLECULE,  2017–2020 (USD MILLION)
                       TABLE 330 ROE: MARKET, BY TYPE OF MOLECULE,  2021–2026 (USD MILLION)
                       TABLE 331 ROE: MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                       TABLE 332 ROE: MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                       TABLE 333 ROE: MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                       TABLE 334 ROE: MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                       TABLE 335 ROE: MARKET, BY END USER, 2017–2020 (USD MILLION)
                       TABLE 336 ROE: MARKET, BY END USER, 2021–2026 (USD MILLION)
     12.4 ASIA PACIFIC
             12.4.1 SIGNIFICANT INVESTMENTS BY BIOPHARMACEUTICAL COMPANIES & CMOS IN EMERGING APAC COUNTRIES TO DRIVE MARKET GROWTH
                       FIGURE 34 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
                       TABLE 337 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
                       TABLE 338 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
                       TABLE 339 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                       TABLE 340 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                       TABLE 341 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION)
                       TABLE 342 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION)
                       TABLE 343 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 344 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 345 ASIA PACIFIC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 346 ASIA PACIFIC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 347 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                       TABLE 348 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                       TABLE 349 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                       TABLE 350 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                       TABLE 351 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                       TABLE 352 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY APPLICATION,  2021–2026 (USD MILLION)
                       TABLE 353 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER,  2017–2020 (USD MILLION)
                       TABLE 354 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.4.2 CHINA
                       12.4.2.1 Government initiatives contribute to the growth of the biopharma industry, thus supporting market growth for SUBs
                                   TABLE 355 CHINA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 356 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 357 CHINA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 358 CHINA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 359 CHINA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 360 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,  2021–2026 (USD MILLION)
                                   TABLE 361 CHINA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 362 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 363 CHINA: SINGLE USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 364 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 365 CHINA: SINGLE USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 366 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.4.3 SOUTH KOREA
                       12.4.3.1 Increasing annual drug exports and quality manufacturing practices to drive the market growth in South Korea
                                   TABLE 367 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT,  2017–2020 (USD MILLION)
                                   TABLE 368 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT,  2021–2026 (USD MILLION)
                                   TABLE 369 SOUTH KOREA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 370 SOUTH KOREA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 371 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 372 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                                   TABLE 373 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 374 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 375 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 376 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 377 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 378 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.4.4 JAPAN
                       12.4.4.1 Expansion of pharmaceutical manufacturing plants in Japan has created growth opportunities for SUB companies
                                   TABLE 379 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 380 JAPAN: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 381 JAPAN: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 382 JAPAN: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 383 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 384 JAPAN: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                                   TABLE 385 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 386 JAPAN: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 387 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 388 JAPAN: SINGLE USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                                   TABLE 389 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 390 JAPAN: SINGLE USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.4.5 INDIA
                       12.4.5.1 The growth of the pharmaceutical industry creates significant demand for SUBs in India
                                   TABLE 391 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                                   TABLE 392 INDIA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                                   TABLE 393 INDIA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                                   TABLE 394 INDIA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                   TABLE 395 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                                   TABLE 396 INDIA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                                   TABLE 397 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                                   TABLE 398 INDIA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                                   TABLE 399 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                                   TABLE 400 INDIA: SINGLE USE BIOREACTORS MARKET, BY APPLICATION,  2021–2026 (USD MILLION)
                                   TABLE 401 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION)
                                   TABLE 402 INDIA: SINGLE USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION)
             12.4.6 ROAPAC
                       TABLE 403 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                       TABLE 404 ROAPAC: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                       TABLE 405 ROAPAC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 406 ROAPAC: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                       TABLE 407 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                       TABLE 408 ROAPAC: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                       TABLE 409 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                       TABLE 410 ROAPAC: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                       TABLE 411 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                       TABLE 412 ROAPAC: SINGLE USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                       TABLE 413 ROAPAC: SINGLE-USE BIOREACTORS MARKET, BY END USER,  2017–2020 (USD MILLION)
                       TABLE 414 ROAPAC: SINGLE USE BIOREACTORS MARKET, BY END USER,  2021–2026 (USD MILLION)
     12.5 LATIN AMERICA (LATAM)
             12.5.1 GROWTH IN THE GENERIC DRUG MARKET WILL INCREASE THE DEMAND FOR SINGLE-USE BIOREACTORS IN LATAM
                       TABLE 415 LATAM: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                       TABLE 416 LATAM: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                       TABLE 417 LATAM: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION)
                       TABLE 418 LATAM: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION)
                       TABLE 419 LATAM: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE,  2017–2020 (USD MILLION)
                       TABLE 420 LATAM: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 421 LATAM: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 422 LATAM: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 423 LATAM: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2017–2020 (USD MILLION)
                       TABLE 424 LATAM: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                       TABLE 425 LATAM: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                       TABLE 426 LATAM: SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                       TABLE 427 LATAM: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
                       TABLE 428 LATAM: SINGLE USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                       TABLE 429 LATAM: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION)
                       TABLE 430 LATAM: SINGLE USE BIOREACTORS MARKET, BY END USER,  2021–2026 (USD MILLION)
     12.6 MIDDLE EAST AND AFRICA (MEA)
             12.6.1 FUNDING INITIATIVES AND RESEARCH ACTIVITIES IN THIS REGION DRIVES THE MARKET GROWTH FOR SUBS
                       TABLE 431 MEA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                       TABLE 432 MEA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
                       TABLE 433 MEA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2017–2020 (USD MILLION)
                       TABLE 434 MEA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2026 (USD MILLION)
                       TABLE 435 MEA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 436 MEA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 437 MEA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2017–2020 (USD MILLION)
                       TABLE 438 MEA: SINGLE-USE BIOREACTORS SYSTEMS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                       TABLE 439 MEA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE,  2017–2020 (USD MILLION)
                       TABLE 440 MEA: SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2026 (USD MILLION)
                       TABLE 441 MEA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2017–2020 (USD MILLION)
                       TABLE 442 MEA: SINGLE SE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2026 (USD MILLION)
                       TABLE 443 MEA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION,  2017–2020 (USD MILLION)
                       TABLE 444 MEA: SINGLE USE BIOREACTORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
                       TABLE 445 MEA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2017–2020 (USD MILLION)
                       TABLE 446 MEA: SINGLE USE BIOREACTORS MARKET, BY END USER, 2021–2026 (USD MILLION)

13 COMPETITIVE LANDSCAPE (Page No. - 290)
     13.1 MARKET EVALUATION FRAMEWORK
     13.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
               FIGURE 35 SINGLE-USE BIOREACTOR MARKET: RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
     13.3 REVENUE ANALYSIS
               FIGURE 36 REVENUE ANALYSIS FOR KEY COMPANIES FOR 2017-2020
     13.4 MARKET SHARE ANALYSIS OF TOP MARKET PLAYERS
               FIGURE 37 MARKET SHARE ANALYSIS: 2020
     13.5 GLOBAL SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION QUADRANT, 2020
               FIGURE 38 GLOBAL SINGLE USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX, 2020
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE
             13.5.4 EMERGING COMPANIES
     13.6 GLOBAL SINGLE-USE BIOREACTORS MARKET: START-UPS/ SMES EVALUATION MATRIX, 2020
               FIGURE 39 GLOBAL SINGLE USE BIOREACTORS MARKET: STARTUP/SME EVALUATION MATRIX (2020)
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 STARTING BLOCKS
             13.6.3 RESPONSIVE COMPANIES
             13.6.4 DYNAMIC COMPANIES
     13.7 COMPETITIVE BENCHMARKING
             13.7.1 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
                       FIGURE 40 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-USE BIOREACTORS MARKET
     13.8 KEY MARKET DEVELOPMENTS
             13.8.1 KEY PRODUCT LAUNCHES
             13.8.2 KEY ACQUISITIONS
             13.8.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
             13.8.4 KEY EXPANSIONS

14 COMPANY PROFILES (Page No. - 303)
     14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             14.1.1 SARTORIUS STEDIM BIOTECH
                       TABLE 447 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
                       FIGURE 41 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)
                       TABLE 448 SARTORIUS STEDIM BIOTECH: PRODUCT OFFERINGS
             14.1.2 DANAHER CORPORATION
                       TABLE 449 DANAHER: BUSINESS OVERVIEW
                       FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
             14.1.3 THERMO FISHER SCIENTIFIC INC.
                       TABLE 450 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                       FIGURE 43 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
                       TABLE 451 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
             14.1.4 MERCK MILLIPORE
                       TABLE 452 MERCK MILLIPORE: BUSINESS OVERVIEW
                       FIGURE 44 MERCK MILLIPORE: COMPANY SNAPSHOT (2020)
                       TABLE 453 MERCK MILLIPORE: PRODUCT OFFERINGS
             14.1.5 GETINGE AB
                       TABLE 454 GETINGE AB: BUSINESS OVERVIEW
                       FIGURE 45 GETINGE: COMPANY SNAPSHOT (2020)
                       TABLE 455 GETINGE AB: PRODUCT OFFERINGS
             14.1.6 EPPENDORF AG
                       TABLE 456 EPPENDORF AG: BUSINESS OVERVIEW
                       FIGURE 46 EPPENDORF AG: COMPANY SNAPSHOT (2020)
                       TABLE 457 EPPENDORF AG: PRODUCT OFFERINGS
             14.1.7 CESCO BIOENGINEERING CO., LTD.
                       TABLE 458 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
                       TABLE 459 CESCO BIOENGINEERING CO., LTD.: PRODUCT OFFERINGS
             14.1.8 CELLEXUS
                       TABLE 460 CELLEXUS: BUSINESS OVERVIEW
                       TABLE 461 CELLEXUS: PRODUCT OFFERINGS
             14.1.9 PBS BIOTECH, INC.
                       TABLE 462 PBS BIOTECH: BUSINESS OVERVIEW
                       TABLE 463 PBS BIOTECH: PRODUCT OFFERINGS
             14.1.10 DISTEK, INC.
                       TABLE 464 DISTEK INC.: BUSINESS OVERVIEW
                       TABLE 465 DISTEK, INC.: PRODUCT OFFERINGS
             14.1.11 ABEC
                       TABLE 466 ABEC: BUSINESS OVERVIEW
                       TABLE 467 ABEC INC.: PRODUCT OFFERINGS
                       TABLE 468 PRODUCT LAUNCHES
             14.1.12 ABLE CORPORATION & BIOTT CORPORATION
                       TABLE 469 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW
                       TABLE 470 ABLE CORPORATION & BIOTT CORPORATION: PRODUCT OFFERINGS
             14.1.13 G&G TECHNOLOGIES, INC.
                       TABLE 471 G&G TECHNOLOGIES: BUSINESS OVERVIEW
                       TABLE 472 G&G TECHNOLOGIES: PRODUCT OFFERINGS
             14.1.14 SOLIDA BIOTECH GMBH
                       TABLE 473 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
                       TABLE 474 SOLIDA BIOTECH GMBH: PRODUCT OFFERINGS
             14.1.15 SATAKE CHEMICAL EQUIPMENT MFG., LTD.
                       TABLE 475 SATAKE CHEMICAL EQUIPMENT MFG., LTD.: BUSINESS OVERVIEW
                       TABLE 476 SATAKE CHEMICAL EQUIPMENTS MFG., LTD.: PRODUCT OFFERINGS
             14.1.16 STOBBE PHARMA GMBH
                       TABLE 477 STOBBE PHARMA GMBH: BUSINESS OVERVIEW
                       TABLE 478 STOBBE PHARMA GMBH: PRODUCT OFFERINGS
             14.1.17 CELLTAINER BIOTECH BV
                       TABLE 479 CELLTAINER BIOTECH: BUSINESS OVERVIEW
                       TABLE 480 CELLTAINER BIOTECH: PRODUCT OFFERINGS
             14.1.18 MEISSNER FILTRATION PRODUCTS, INC.
                       TABLE 481 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW
                       TABLE 482 MEISSNER FILTRATION PRODUCTS INC.: PRODUCT OFFERINGS
             14.1.19 BBI-BIOTECH GMBH
                       TABLE 483 BBI BIOTECH GMBH: BUSINESS OVERVIEW
             14.1.20 PRODUCTS OFFERED
                       TABLE 484 BBI BIOTECH GMBH.: PRODUCT OFFERINGS
             14.1.21 ENDEL ENGIE
                       TABLE 485 ENDEL ENGINE: BUSINESS OVERVIEW
                       TABLE 486 ENDEL ENGINE: PRODUCT OFFERINGS
     14.2 START-UP PLAYERS
             14.2.1 OMNIBRX BIOTECHNOLOGIES
             14.2.2 NEW HORIZON BIOTECHNOLOGY INC.
             14.2.3 GPC BIO
             14.2.4 CELL CULTURE COMPANY
             14.2.5 APTUS BIOREACTORS

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX (Page No. - 362)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.3 AVAILABLE CUSTOMIZATIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the single-use bioreactor market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Data

This research study involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies’ house documents, investor presentations, and SEC filings of companies. The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), National Institutes of Health (NIH), World Bank, United States Food and Drug Administration (US FDA), US Census Bureau, National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Germany Trade and Invest (GTAI), Bio-Process Systems Alliance (BPSA), European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, Eurostat among others. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the single-use bioreactor market. It was also used to obtain important information about the key players and market classification, segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Data

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

Primary sources from demand side includes personnel from pharmaceutical and biotechnology companies and academic and research institutes, and purchase managers in healthcare provider organizations and supply-side includes C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others.

Primary research was used in this report to:

  • Validate the market segmentation defined through product portfolio assessment of leading players in the single-use bioreactors market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of key factors affecting the market growth (such as market drivers, challenges, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the single-use bioreactor market and their market share/ranking

Single-use Bioreactors Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the single-use bioreactors market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the market

Report Objectives

  • To define, describe, segment, and forecast the single-use bioreactors market on the basis of product, type, type of cell, type of molecule, application, end user, and region
  • To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-use bioreactors market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
  • To strategically profile the key players in the global market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments, such as product launches, acquisitions, collaborations, expansions, and partnerships in the single-use bioreactor market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the European single-use bioreactors market into countries from the Rest of Europe segment.
  • Further breakdown of the Asia Pacific single-use bioreactors market into countries from the Rest of the APAC segment.
  • Further breakdown of Latin America and the Middle East & Africa market into countries.

Company Information

Detailed analysis and profiling of additional market players (up to 5) inclusive of:

  • Business Overview
  • Financial Information
  • Product Offered
  • Developments (Last three years)
Report Code
BT 2863
Published ON
Aug, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Single Use Bioreactors Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback